2Lehunann DF,Guharoy,Page N,et al.Formulary management as a tool to improve medication use and gain physician support.Am J Health Syst Pharm,2007,64(5):464-466.
3Smetana GW,Davis RB,Phillips RS.Factors that influence patient response to requests to change to a unified restrictive for-mulary.J Gen Intern Med,2004,19(12):1212-1219.
4Olson BM.Approaches to pharmacy benefit management and the impact of consumer cost sharing.Clin Ther,2003,25(1):250-272.
5Stolar MH.National survey of hospital pharmaceutical services.Am J Hosp Pharm,1985,42(12):2667-2678.
2WHO. How to Develop a National Formulary Based on the WHO Model Formulary[EB/OL ] . http://whqlibdoc .who .int/hq/2004/WHO EDM PAR 2004.8. pdf.2004.2007- 10- 21.
3Bruce H. Best Practice for Hospital & Health - System Pharmacy [ M ] . Bethesda : ASHP, 2005 : 107, 109-110,113.
4FDA. Approved Drug Products with Therapeutic E- quivalence Evaluations. 27th [ EB/OL] . http ://www. fda .gov/cder/orange/. 2007. 2007 - 10 - 21.
